Author:
Vesole DH,Simic A,Lazarus HM
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference108 articles.
1. Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome New Engl J Med 1996 335: 91–97
2. Gahrton G, Svensson H, Cavo M et al. Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–8 at European Group for Blood and Marrow Transplantation centres Br J Haematol 2001 113: 209–216
3. Rajkumar SV, Hayman S, Fonseca R et al. Thalidomide plus dexamethasone (THAL/DEX) and thalidomide alone (THAL) as first line therapy for newly diagnosed multiple myeloma (MM) Blood 2000 96: (Suppl. 1) 168a (Abstr. 722)
4. Barlogie B, Spencer T, Tricot G et al. Long term follow up of 169 patients receiving a phase II trial of single agent thalidomide for advanced and refractory multiple myeloma Blood 2000 96: (Suppl. 1) 514a (Abstr. 2213)
5. Moreau P, Milpied N, Mahe B et al. Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma Bone Marrow Transplant 1999 23: 1003–1006
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献